XTER:COP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XTER:COP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, CompuGroup Medical SE KgaA's Enterprise Value is €1,891 Mil. CompuGroup Medical SE KgaA's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was €69 Mil. Therefore, CompuGroup Medical SE KgaA's EV-to-EBIT for today is 27.29.
The historical rank and industry rank for CompuGroup Medical SE KgaA's EV-to-EBIT or its related term are showing as below:
During the past 13 years, the highest EV-to-EBIT of CompuGroup Medical SE KgaA was 49.98. The lowest was 17.87. And the median was 27.89.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. CompuGroup Medical SE KgaA's Enterprise Value for the quarter that ended in Sep. 2024 was €1,508 Mil. CompuGroup Medical SE KgaA's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was €69 Mil. CompuGroup Medical SE KgaA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 4.59%.
The historical data trend for CompuGroup Medical SE KgaA's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CompuGroup Medical SE KgaA Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
EV-to-EBIT | Get a 7-Day Free Trial | 31.50 | 40.41 | 42.24 | 22.21 | 27.65 |
CompuGroup Medical SE KgaA Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
EV-to-EBIT | Get a 7-Day Free Trial | 20.16 | 27.65 | 21.63 | 27.71 | 21.92 |
For the Health Information Services subindustry, CompuGroup Medical SE KgaA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, CompuGroup Medical SE KgaA's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where CompuGroup Medical SE KgaA's EV-to-EBIT falls into.
CompuGroup Medical SE KgaA's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 1891.273 | / | 69.298 | |
= | 27.29 |
CompuGroup Medical SE KgaA's current Enterprise Value is €1,891 Mil.
CompuGroup Medical SE KgaA's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €69 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CompuGroup Medical SE KgaA (XTER:COP) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
CompuGroup Medical SE KgaA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Sep. 2024 ) | = | EBIT | / | Enterprise Value (Q: Sep. 2024 ) |
= | 69.298 | / | 1508.4407 | |
= | 4.59 % |
CompuGroup Medical SE KgaA's Enterprise Value for the quarter that ended in Sep. 2024 was €1,508 Mil.
CompuGroup Medical SE KgaA's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €69 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Daniela Hommel | CFO, Managing director of the general partner of the issuer | |
Michael Rauch | Managing director of the general partner of the issuer | |
Emanuele Mugnani | Managing director of the general partner of the issuer | |
Frank Gotthardt | Chairman of Administrative Board of CompuGroup Medical Management SE | |
Prof. (apl.) Dr. Med Daniel Gotthardt | Member of the Administrative Board of CompuGroup Medical Management SE | |
Hannes Reichl | Managing director of the general partner of the issuer | |
Dr. Eckart Pech | Managing director of the general partner of the issuer | |
Dr. Dirk Wössner | CEO, Managing director of the general partner of the issuer | |
Dr. Ralph Körfgen | Managing director of the general partner of the issuer |
From GuruFocus
By GuruFocus News • 11-01-2024
By GuruFocus News • 11-25-2024
By Business Wire • 11-25-2024
By Khac Phu Nguyen • 10-31-2024
By GuruFocus News • 11-22-2024
By GuruFocus Research • 08-01-2024
By Business Wire • 06-20-2024
By GuruFocus News • 11-25-2024
By Business Wire • 09-19-2024
By GuruFocus News • 11-23-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.